GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (FRA:2CV) » Definitions » Selling and Marketing Expense

ConvaTec Group (FRA:2CV) Selling and Marketing Expense : €581 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. ConvaTec Group's Selling and Marketing Expense for the six months ended in Jun. 2024 was €299 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €581 Mil.

ConvaTec Group Selling and Marketing Expense Historical Data

The historical data trend for ConvaTec Group's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group Selling and Marketing Expense Chart

ConvaTec Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 413.01 380.83 477.64 543.65 561.66

ConvaTec Group Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 271.79 272.44 281.24 282.25 299.23

ConvaTec Group Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €581 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ConvaTec Group Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ConvaTec Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (FRA:2CV) » Definitions » Selling and Marketing Expense
Comparable Companies
LSE:AMS LSE:TSTL LSE:BVC LSE:SPEC LSE:CNSL ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX XPAR:DIM HOLX TSE:7733 COO
Traded in Other Exchanges
CNVVF:USA CNVVY:USA CTECl:UK CTEC:UK
Address
20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG
Website
https://www.convatecgroup.com
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

ConvaTec Group Headlines

No Headlines